231 related articles for article (PubMed ID: 37669313)
1. Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation.
Olson AT; Kang Y; Ladha AM; Zhu S; Lim CB; Nabet B; Lagunoff M; Gujral TS; Geballe AP
PLoS Pathog; 2023 Sep; 19(9):e1011169. PubMed ID: 37669313
[TBL] [Abstract][Full Text] [Related]
2. Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation.
Olson AT; Kang Y; Ladha AM; Lim CB; Lagunoff M; Gujral TS; Geballe AP
bioRxiv; 2023 Feb; ():. PubMed ID: 36778430
[TBL] [Abstract][Full Text] [Related]
3. ARID3B: a Novel Regulator of the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle.
Wood JJ; Boyne JR; Paulus C; Jackson BR; Nevels MM; Whitehouse A; Hughes DJ
J Virol; 2016 Oct; 90(20):9543-55. PubMed ID: 27512077
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ.
Zhang L; Zhu C; Guo Y; Wei F; Lu J; Qin J; Banerjee S; Wang J; Shang H; Verma SC; Yuan Z; Robertson ES; Cai Q
J Virol; 2014 Jun; 88(12):6873-84. PubMed ID: 24696491
[TBL] [Abstract][Full Text] [Related]
5. Targeting Kaposi's Sarcoma-Associated Herpesvirus ORF21 Tyrosine Kinase and Viral Lytic Reactivation by Tyrosine Kinase Inhibitors Approved for Clinical Use.
Beauclair G; Naimo E; Dubich T; Rückert J; Koch S; Dhingra A; Wirth D; Schulz TF
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826996
[TBL] [Abstract][Full Text] [Related]
6. FoxO1 Suppresses Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication and Controls Viral Latency.
Gao R; Li T; Tan B; Ramos da Silva S; Jung JU; Feng P; Gao SJ
J Virol; 2019 Feb; 93(3):. PubMed ID: 30404794
[TBL] [Abstract][Full Text] [Related]
7. Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication.
Abere B; Samarina N; Gramolelli S; Rückert J; Gerold G; Pich A; Schulz TF
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950425
[TBL] [Abstract][Full Text] [Related]
8. Screening of the Human Kinome Identifies MSK1/2-CREB1 as an Essential Pathway Mediating Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication during Primary Infection.
Cheng F; Sawant TV; Lan K; Lu C; Jung JU; Gao SJ
J Virol; 2015 Sep; 89(18):9262-80. PubMed ID: 26109721
[TBL] [Abstract][Full Text] [Related]
9. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
Sanchez EL; Pulliam TH; Dimaio TA; Thalhofer AB; Delgado T; Lagunoff M
J Virol; 2017 May; 91(10):. PubMed ID: 28275189
[TBL] [Abstract][Full Text] [Related]
10. Complex Interactions between Cohesin and CTCF in Regulation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription.
Li D; Mosbruger T; Verma D; Swaminathan S
J Virol; 2020 Jan; 94(2):. PubMed ID: 31666380
[TBL] [Abstract][Full Text] [Related]
11. Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
Chang PJ; Chen LW; Chen LY; Hung CH; Shih YJ; Wang SS
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701396
[TBL] [Abstract][Full Text] [Related]
12. The inflammatory kinase MAP4K4 promotes reactivation of Kaposi's sarcoma herpesvirus and enhances the invasiveness of infected endothelial cells.
Haas DA; Bala K; Büsche G; Weidner-Glunde M; Santag S; Kati S; Gramolelli S; Damas M; Dittrich-Breiholz O; Kracht M; Rückert J; Varga Z; Keri G; Schulz TF
PLoS Pathog; 2013; 9(11):e1003737. PubMed ID: 24244164
[TBL] [Abstract][Full Text] [Related]
13. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
Smith CG; Kharkwal H; Wilson DW
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
[TBL] [Abstract][Full Text] [Related]
14. Regulation of KSHV Latency and Lytic Reactivation.
Broussard G; Damania B
Viruses; 2020 Sep; 12(9):. PubMed ID: 32957532
[TBL] [Abstract][Full Text] [Related]
15. Cellular MicroRNA Let-7a Suppresses KSHV Replication through Targeting MAP4K4 Signaling Pathways.
Tan X; Gao Y; Nan Y; Zhang J; Di C; Wang X; Lian F; Cao Y; Hu Y; Xu L; Ma H; Hong Y; Liu T; Wu Y; Xu X; Yan Y; Yang L
PLoS One; 2015; 10(7):e0132148. PubMed ID: 26197270
[TBL] [Abstract][Full Text] [Related]
16. Nuclear Innate Immune DNA Sensor IFI16 Is Degraded during Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus (KSHV): Role of IFI16 in Maintenance of KSHV Latency.
Roy A; Dutta D; Iqbal J; Pisano G; Gjyshi O; Ansari MA; Kumar B; Chandran B
J Virol; 2016 Oct; 90(19):8822-41. PubMed ID: 27466416
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways.
Xie J; Ajibade AO; Ye F; Kuhne K; Gao SJ
Virology; 2008 Feb; 371(1):139-54. PubMed ID: 17964626
[TBL] [Abstract][Full Text] [Related]
18. Genome-Wide Identification of Direct RTA Targets Reveals Key Host Factors for Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.
Papp B; Motlagh N; Smindak RJ; Jin Jang S; Sharma A; Alonso JD; Toth Z
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541837
[TBL] [Abstract][Full Text] [Related]
19. Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latency.
Ye F; Zhou F; Bedolla RG; Jones T; Lei X; Kang T; Guadalupe M; Gao SJ
PLoS Pathog; 2011 May; 7(5):e1002054. PubMed ID: 21625536
[TBL] [Abstract][Full Text] [Related]
20. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
